Enlarged prostate or BPH treatment with Dr Allen’s Device protects from COVID-19

Dr Allen's Device helps men with prostate enlargement to experience the much-desired pelvic pain relief and reduce enlarged prostate size, easing urination problems in patients with benign prostatic hyperplasia (BPH). Its efficacy has been confirmed by 10 successful years on the market and solid medical data.

The praise for non-surgical treatment with Dr Allen’s Device is evident in another recent medical article. “Innovative thermobalancing therapy and Dr Allen's Device for the first time employ body energy to treat chronic prostatic diseases effectively” article was published by Springer Nature in the leading International Journal of Quality Innovation.

This article shows that the unique design of Dr Allen’s Device utilises the emitted body heat in non-invasive pelvic pain relief, and for the reduction of the abnormal size of the enlarged or inflamed prostate gland and lower urinary tract symptoms (LUTS). Thus, the wearable Dr Allen's Device is the only clinically proven product that actually treats the cause of BPH, prostatitis and the troubling urinary symptoms.

Medications and surgery for enlarged prostate are dangerous

In comparison, prescribed prostate medications feature poorly when results are reviewed: while they are intended to ease pelvic pain and urinary symptoms, medications do not actually treat the cause of prostate problems. Some symptoms just get masked only to get worse later down the line. Moreover, all medications are proven to have side-effects that are responsible for serious complications for men.

Different surgical procedures turn into a total nightmare for many men. There are many of them, such as transurethral resection of the prostate, transurethral laser ablation, and so on. All of them often have a negative impact on men's health, and are associated with sexual dysfunction, which in turn, causes mental health issues and depression in almost 25% of patients in BPH. These severe mental issues have compelled most urologists to stop performing surgical interventions in men with chronic prostatitis and pelvic pain.

Protection from COVID-19 with Dr Allen's Device

Many scientific articles call for new strategies for treating urologic diseases during COVID-19. Management of patients with BPH is guided by pharmacological interventions mainly alpha blockers and 5-alpha reductase inhibitors, which can develop serious side effects; and therefore, they should be administered carefully, especially during a COVID-19 pandemic.

The proposed triage of surgical cases during the COVID-19 pandemic includes deferral with BPH procedures (TURP, HoLEP, PVP laser, etc.), and urinary tract obstruction can be adequately treated with a urethral or suprapubic catheter without the need for a procedure under anesthesia. During COVID-19, special strategies should be used to treat urological conditions, based on the golden rule for any infectious disease at any time: “prevention is better than cure”.

Dr Allen’s Device for Prostate Treatment provides effective therapy at home. This minimizes the risk of virus transmission during a Coronavirus pandemic by reducing the number of hospital visits and patient contact with different healthcare providers.

Dr Allen’s Device is essential for aging men

Clinical studies on thermobalancing therapy and Dr Allen’s Device, registered with the World Health Organisation, confirm their effectiveness for men with BPH and chronic prostatitis. Many scientific articles published in leading medical journals can be viewed on the dedicated Fine Treatment.

The delivery of Dr Allen's Device is guaranteed by royal mail tracking service. Fine Treatment is a manufacturer and distributor of non-invasive Dr Allen’s Device, and is a UK Department for International Trade (DIT) registered supplier to international buyers.

Disclaimer: No Deccan Chronicle journalist was involved in creating this content. The group also takes no responsibility for this content.